APD
52
-2
MDT
50
-2
K
45
4
AIZ
71
3
AME
50
-4
MS
65
3
DVN
32
-4
PHM
48
-4
MDLZ
53
2
ADM
56
-3
VIX
54
8
TMO
47
-5
AIG
53
-3
SNA
60
14
ZTS
36
2
LEN
41
-3
COP
42
-3
EA
46
2
HBI
59
-3
LOW
40
-2
APD
52
-2
MDT
50
-2
K
45
4
AIZ
71
3
AME
50
-4
MS
65
3
DVN
32
-4
PHM
48
-4
MDLZ
53
2
ADM
56
-3
VIX
54
8
TMO
47
-5
AIG
53
-3
SNA
60
14
ZTS
36
2
LEN
41
-3
COP
42
-3
EA
46
2
HBI
59
-3
LOW
40
-2
Financhill
Back

Kymera Therapeutics Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
58

KYMR
Kymera Therapeutics

Last Price:
$44.94
Seasonality Move:
5.78%

7 Day Trial

ALL ACCESS PASS

$ 7

Kymera Therapeutics Stock Forecast

  • Over the next 52 weeks, Kymera Therapeutics has on average historically risen by 6.2% based on the past 4 years of stock performance.
  • Kymera Therapeutics has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is Kymera Therapeutics Stock Undervalued?
    The current Kymera Therapeutics [KYMR] share price is $44.90. The Score for KYMR is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Kymera Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Kymera Therapeutics has on average historically risen by 6.2% based on the past 4 years of stock performance.

Kymera Therapeutics Stock Rating

Buy
58
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics overpriced?

  • Kymera Therapeutics has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Kymera Therapeutics Stock Price History

Is KYMR stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kymeratx.com

52-Week Data

52-Week High:
53.27
52-Week Low:
19.45

Prediction Charts

Market Cap:
2.9B
Price in USD:
44.90
Volume:
569.6K
Beta:
2.16

Technical Analysis

SMA50:
39.36
SMA100:
34.99
SMA200:
39.49
52-Wk Change:
6.15%

Stock Predictions

  • Is Kymera Therapeutics stock public?
    Yes, Kymera Therapeutics is a publicly traded company.
  • What is the Kymera Therapeutics stock quote today?
    The Kymera Therapeutics stock price is 44.90 USD today.
  • How to buy Kymera Therapeutics stock online?
    You can buy Kymera Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-24 47.30 47.14 47.73 45.89
Jun-25 45.56 46.47 46.82 44.62
Jun-26 45.51 45.71 46.21 44.00
Jun-27 46.43 44.12 46.67 43.51
Jun-30 44.66 43.64 45.03 43.58
Jul-1 45.02 44.44 45.45 43.84
Jul-2 44.70 44.53 45.46 44.08
Jul-3 45.04 44.79 45.15 44.26
Jul-7 44.46 43.81 44.46 43.00
Jul-8 44.02 43.43 44.41 42.87
Jul-9 43.62 45.18 46.34 43.62
Jul-10 45.14 45.21 45.38 43.56
Jul-11 44.57 44.48 45.15 43.87
Jul-14 44.63 44.90 45.83 44.41

Kymera Therapeutics Earnings

Kymera Therapeutics Earnings Report: Per Share Kymera Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Kymera Therapeutics Forecast Revenue Growth

Kymera Therapeutics Stock Analysis: Historical quarterly revenues per share for Kymera Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.20 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.41 per share.

* Kymera Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.